Therefore, larger, preferably population-based case-control studies, as well as mechanistic studies involving variants of VEGFA on glioma progression, are warranted to validate our findings and to further investigate their roles in the development of glioma. The gene discussed is VEGFA; the disease is central nervous system cancer.